Perceptive Advisors LLC Dynavax Technologies Corp Transaction History

Perceptive Advisors LLC

  • $3 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$4.32 - $11.7 $764,424 - $2.07 Million
-176,950 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$2.94 - $9.1 $520,233 - $1.61 Million
176,950 New
176,950 $1.57 Million
Q2 2018

Aug 14, 2018
SELL
$15.15 - $20.75 $844,051 - $1.16 Million
-55,713 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$14.65 - $19.9 $816,195 - $1.11 Million
55,713 New
55,713 $1.11 Million

Others Institutions Holding DVAX

# of Institutions
288
Shares Held
131M
Call Options Held
507K
Put Options Held
374K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.7B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email